Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IVIG for neonatal suspected serious infection
ACTRN12606000273583Phase 3Completed
- Sponsor
- The University of Sydney
- Start
- Feb 2002
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in neonatal sepsis and neonatal infection comparing Intragam P with Placebo saline (2 arms). Primary endpoint: Mortality or major disability. Started Feb 2002; status: completed.
02
Drugs
Intragam P
03
Conditions
neonatal sepsisneonatal infection
Beyond the preview
Go deeper on ACTRN12606000273583.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12606000273583.